Point of Care Testing Market Size Forecast Between 2022 – 2030

Point of Care Testing Market Size Forecast Between 2022 – 2030

Acumen Research and Consulting has recently published a research report on the Point of Care Testing Market for the forecast period of 2022-2030, wherein, the global market has been analyzed and assessed in an extremely comprehensive manner.

The research report on the Point of Care Testing Market offers an extensive analysis of how the Point of Care Testing Market landscape would evolve through 2030.

A deep dive study on this industry has enabled our research analysts to precisely analyze the Point of Care Testing Market size. Additionally, our Point of Care Testing Market forecast numbers have been updated on account of the impact COVID-19 pandemic and this has helped us to estimate the final worldwide Point of Care Testing Market value.

The research study on the Point of Care Testing Market analyzes key drivers upholding product sales and prominent trends shaping the growth of the market.

The research study not only focuses on the latent opportunities for the key stakeholders of the market but also sheds light on the notable developments and future scope for innovation in the landscape

Download Sample Report Copy Of This Report From Here: https://www.acumenresearchandconsulting.com/request-sample/1136

The report starts with a quick executive summary, wherein, key takeaways have been highlighted for the readers to have a sneak peek at the key market segments. In addition, the research study also focuses on Point of Care Testing Market trends that are responsible for market growth.

The research study by Acumen Research and Consulting on the market also talks about the macroeconomic and microeconomic factors having deep-rooted influences on global Point of Care Testing Market growth.

The research study on the Point of Care Testing Market industry analysis also offers a regional analysis, wherein, demand across every region has been comprehensively analyzed.

Our Point of Care Testing Market regional outlook will allow you to comprehend information on a worldwide level. Besides that, it will make you easily uncover the Point of Care Testing Market shares of all the segmentations and regions.

Point of Care Testing MarketKey Vendors Included as below:

Some of the global point of care testing companies included in the report is Abbott Laboratories, Becton Dickinson (BD), Biomerieux SA, Danaher Corp., F. Hoffmann-La Roche Ltd., Instrumentation Laboratory, Nova Biomedical, Qiagen, Siemens Healthcare AG, Trividia Health, Inc., and Zoetis, Inc.

Key Questions Answered in the Report

The report addresses key questions concerning the market evolution and overarching trends shaping global market growth. Some of the key questions answered in the report include-

  • What is the overall structure of the market?
  • What was the historical value and what is the forecasted value of the market?
  • What are the key product level trends in the market?
  • What are the market level trends in the market?
  • Which of the market players are leading and what are their key differential strategies to retain their stronghold?
  • Which are the most lucrative regions in the market space?

Point of Care Testing Market Segmentation for this report is as below:

Point of Care Testing Market By Product

  • Glucose Monitoring
    • Strips
    • Meters
    • Lancets
  • Cardiometabolic Testing Products
    • Cardiac Marker Testing Products
    • Blood Gas/Electrolytes Testing Products
    • HBA1C Testing Products
  • Infectious Disease Testing Products
    • Influenza Testing Products
    • HIV Testing Products
    • Hepatitis C Testing Products
    • Sexually Transmitted Disease (STD) Testing Products
    • Healthcare-Associated Infection (HAI) Testing Products
    • Respiratory Infection Testing Products
    • Tropical Disease Testing Products
    • Other Infectious Diseases Testing Products
  • Coagulation Testing Products
    • PT/INR Testing Products
    • Activated Clotting Time (ACT/APTT) Testing Products
  • Pregnancy and Fertility Testing Products
    • Pregnancy Testing Products
    • Fertility Testing Products
  • Tumor/Cancer Marker Testing Products
  • Urinalysis Testing Products
  • Cholesterol Testing Products
  • Hematology Testing Products
  • Drug-Of-Abuse (DoA) Testing Products
  • Fecal Occult Testing Products
  • Other Products

Point of Care Testing Market By Technology

  • Lateral Flow Assays
  • Dipsticks
  • Microfluidics
  • Molecular Diagnostics
  • Immunoassays
  • Agglutination Assays
  • Flow-Through
  • Solid Phase
  • Biosensors

Point of Care Testing Market By Prescription

  • OTC Testing
  • Prescription-Based Testing

Point of Care Testing Market By Application

  • Cardio Metabolic Testing
  • Infectious Disease Testing
  • Nephrology Testing
  • Drug-of-Abuse (DoA) Testing
  • Blood Glucose Testing
  • Pregnancy Testing
  • Cancer Biomarker Testing
  • Other Applications

Point of Care Testing Market By End-User

  • Hospitals & Clinics
  • Home-Care Settings
  • Assisted Living Healthcare Facilities
  • Laboratories
  • Others

Table of Content:

CHAPTER 1. Industry Overview of Point of Care Testing Market

1.1. Definition and Scope

1.1.1. Definition of Point of Care Testing

1.1.2. Market Segmentation

1.1.3. Years Considered for the Study

1.1.4. Assumptions and Acronyms Used

1.1.4.1. Market Assumptions and Market Forecast

1.1.4.2. Acronyms Used in Global Point of Care Testing Market

1.2. Summary

1.2.1. Executive Summary

1.2.2. Point of Care Testing Market By Product

1.2.3. Point of Care Testing Market By Technology

1.2.4. Point of Care Testing Market By Prescription

1.2.5. Point of Care Testing Market By Application

1.2.6. Point of Care Testing Market By End-User

1.2.7. Point of Care Testing Market By Region

CHAPTER 2. Research Approach

2.1. Methodology

2.1.1. Research Programs

2.1.2. Market Size Estimation

2.1.3. Market Breakdown and Data Triangulation

2.2. Data Source

2.2.1. Secondary Sources

2.2.2. Primary Sources

CHAPTER 3. Market Dynamics And Competition Analysis

3.1. Market Drivers

3.1.1. Driver 1

3.1.2. Driver 2

3.2. Restraints and Challenges

3.2.1. Restraint 1

3.2.2. Restraint 2

3.3. Growth Opportunities

3.3.1. Opportunity 1

3.3.2. Opportunity 2

3.4. Porter’s Five Forces Analysis

3.4.1. Bargaining Power of Suppliers

3.4.2. Bargaining Power of Buyers

3.4.3. Threat of Substitute

3.4.4. Threat of New Entrants

3.4.5. Degree of Competition

3.5. Market Concentration Ratio and Market Maturity Analysis of Point of Care Testing Market

3.5.1. Go To Market Strategy

3.5.1.1. Introduction

3.5.1.2. Growth

3.5.1.3. Maturity

3.5.1.4. Saturation

3.5.1.5. Possible Development

3.6. Technological Roadmap for Point of Care Testing Market

3.7. Value Chain Analysis

3.7.1. List of Key Manufacturers

3.7.2. List of Customers

3.7.3. Level of Integration

3.8. Regulatory Compliance

3.9. Competitive Landscape, 2021

3.9.1. Player Positioning Analysis

3.9.2. Key Strategies Adopted By Leading Players

CHAPTER 4. Point of Care Testing Market By Product

4.1. Introduction

4.2. Point of Care Testing Revenue By Product

4.2.1. Point of Care Testing Revenue (USD Billion) and Forecast, By Product, 2018-2030

4.2.2. Glucose Monitoring

4.2.2.1. Glucose Monitoring Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

4.2.2.2. Strips

4.2.2.2.1. Strips Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

4.2.2.3. Meters

4.2.2.3.1. Meters Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

4.2.2.4. Lancets

4.2.2.4.1. Lancets Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

4.2.3. Cardiometabolic Testing Products

4.2.3.1. Cardiometabolic Testing Products Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

4.2.3.2. Cardiac Marker Testing Products

4.2.3.2.1. Cardiac Marker Testing Products Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

4.2.3.3. Blood Gas/Electrolytes Testing Products

4.2.3.3.1. Blood Gas/Electrolytes Testing Products Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

4.2.3.4. HBA1C Testing Products

4.2.3.4.1. HBA1C Testing Products Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

4.2.4. Infectious Disease Testing Products

4.2.4.1. Infectious Disease Testing Products Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

4.2.4.2. Influenza Testing Products

4.2.4.2.1. Influenza Testing Products Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

4.2.4.3. HIV Products Testing

4.2.4.3.1. HIV Testing Products Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

4.2.4.4. Hepatitis C Testing Products

4.2.4.4.1. Hepatitis C Testing Products Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

4.2.4.5. Sexually Transmitted Disease (STD) Testing Products

4.2.4.5.1. Sexually Transmitted Disease (STD) Testing Products Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

4.2.4.6. Healthcare-Associated Infection (HAI) Testing Products

4.2.4.6.1. Healthcare-Associated Infection (HAI) Testing Products Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

4.2.4.7. Respiratory Infection Testing Products

4.2.4.7.1. Respiratory Infection Testing Products Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

4.2.4.8. Tropical Disease Testing Products

4.2.4.8.1. Tropical Disease Testing Products Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

4.2.4.9. Other Infectious Diseases Testing Products

4.2.4.9.1. Other Infectious Diseases Testing Products Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

4.2.5. Coagulation Testing Products

4.2.5.1. Coagulation Testing Products Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

4.2.5.2. PT/INR Testing Products

4.2.5.2.1. PT/INR Testing Products Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

4.2.5.3. Activated Clotting Time (ACT/APTT) Testing Products

4.2.5.3.1. Activated Clotting Time (ACT/APTT) Testing Products Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

4.2.6. Pregnancy and Fertility Testing Products

4.2.6.1. Pregnancy and Fertility Testing Products Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

4.2.6.2. Pregnancy Testing Products

4.2.6.2.1. Pregnancy Testing Products Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

4.2.6.3. Fertility Testing Products

4.2.6.3.1. Fertility Testing Products Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

4.2.7. Tumor/Cancer Marker Testing Products

4.2.7.1. Tumor/Cancer Marker Testing Products Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

4.2.8. Urinalysis Testing Products

4.2.8.1. Urinalysis Testing Products Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

4.2.9. Cholesterol Testing Products

4.2.9.1. Cholesterol Testing Products Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

4.2.10. Hematology Testing Products

4.2.10.1. Hematology Testing Products Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

4.2.11. Drug-of-Abuse (DoA) Testing Products

4.2.11.1. Drug-of-Abuse (DoA) Testing Products Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

4.2.12. Fecal Occult Testing Products

4.2.12.1. Fecal Occult Testing Products Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

4.2.13. Other Products

4.2.13.1. Other Products Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

CHAPTER 5. Point of Care Testing Market By Technology

5.1. Introduction

5.2. Point of Care Testing Revenue By Application

5.2.1. Point of Care Testing Revenue (USD Billion) and Forecast, By Application, 2018-2030

5.2.2. Lateral Flow Assays

5.2.2.1. Lateral Flow Assays Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

5.2.3. Dipsticks

5.2.3.1. Dipsticks Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

5.2.4. Microfluidics

5.2.4.1. Microfluidics Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

5.2.5. Molecular Diagnostics

5.2.5.1. Molecular Diagnostics Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

5.2.6. Immunoassays

5.2.6.1. Immunoassays Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

5.2.7. Agglutination Assays

5.2.7.1. Agglutination Assays Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

5.2.8. Flow-Through

5.2.8.1. Flow-Through Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

5.2.9. Solid Phase

5.2.9.1. Solid Phase Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

5.2.10. Biosensors

5.2.10.1. Biosensors Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

CHAPTER 6. Point of Care Testing Market By Prescription

6.1. Introduction

6.2. Point of Care Testing Revenue By Prescription

6.2.1. Point of Care Testing Revenue (USD Billion) and Forecast, By Prescription, 2018-2030

6.2.2. OTC Testing

6.2.2.1. OTC Testing Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

6.2.3. Prescription-Based Testing

6.2.3.1. Prescription-Based Testing Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

CHAPTER 7. Point of Care Testing Market By Application

7.1. Introduction

7.2. Point of Care Testing Revenue By Application

7.2.1. Point of Care Testing Revenue (USD Billion) and Forecast, By Application, 2018-2030

7.2.2. Cardio Metabolic Testing

7.2.2.1. Cardio Metabolic Testing Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

7.2.3. Infectious Disease Testing

7.2.3.1. Infectious Disease Testing Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

7.2.4. Nephrology Testing

7.2.4.1. Nephrology Testing Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

7.2.5. Drug-of-Abuse (DoA) Testing

7.2.5.1. Drug-of-Abuse (DoA) Testing Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

7.2.6. Blood Glucose Testing

7.2.6.1. Blood Glucose Testing Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

7.2.7. Pregnancy Testing

7.2.7.1. Pregnancy Testing Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

7.2.8. Cancer Biomarker Testing

7.2.8.1. Cancer Biomarker Testing Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

7.2.9. Other Applications

7.2.9.1. Other Applications Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

CHAPTER 8. Point of Care Testing Market By End-User

8.1. Introduction

8.2. Point of Care Testing Revenue By End-User

8.2.1. Point of Care Testing Revenue (USD Billion) and Forecast, By End-User, 2018-2030

8.2.2. Hospitals & Clinics

8.2.2.1. Hospitals & Clinics Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

8.2.3. Home-Care Settings

8.2.3.1. Home-Care Settings Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

8.2.4. Assisted Living Healthcare Facilities

8.2.4.1. Assisted Living Healthcare Facilities Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

8.2.5. Laboratories

8.2.5.1. Laboratories Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

8.2.6. Others

8.2.6.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

CHAPTER 9. North America Point of Care Testing Market By Country

9.1. North America Point of Care Testing Market Overview

9.2. U.S.

9.2.1. U.S. Point of Care Testing Revenue (USD Billion) and Forecast By Product, 2018-2030

9.2.2. U.S. Point of Care Testing Revenue (USD Billion) and Forecast By Technology, 2018-2030

9.2.3. U.S. Point of Care Testing Revenue (USD Billion) and Forecast By Prescription, 2018-2030

9.2.4. U.S. Point of Care Testing Revenue (USD Billion) and Forecast By Application, 2018-2030

9.2.5. U.S. Point of Care Testing Revenue (USD Billion) and Forecast By End-User, 2018-2030

9.3. Canada

9.3.1. Canada Point of Care Testing Revenue (USD Billion) and Forecast By Product, 2018-2030

9.3.2. Canada Point of Care Testing Revenue (USD Billion) and Forecast By Technology, 2018-2030

9.3.3. Canada Point of Care Testing Revenue (USD Billion) and Forecast By Prescription, 2018-2030

9.3.4. Canada Point of Care Testing Revenue (USD Billion) and Forecast By Application, 2018-2030

9.3.5. Canada Point of Care Testing Revenue (USD Billion) and Forecast By End-User, 2018-2030

9.4. North America PEST Analysis

CHAPTER 10. Europe Point of Care Testing Market By Country

10.1. Europe Point of Care Testing Market Overview

10.2. U.K.

10.2.1. U.K. Point of Care Testing Revenue (USD Billion) and Forecast By Product, 2018-2030

10.2.2. U.K. Point of Care Testing Revenue (USD Billion) and Forecast By Technology, 2018-2030

10.2.3. U.K. Point of Care Testing Revenue (USD Billion) and Forecast By Prescription, 2018-2030

10.2.4. U.K. Point of Care Testing Revenue (USD Billion) and Forecast By Application, 2018-2030

10.2.5. U.K. Point of Care Testing Revenue (USD Billion) and Forecast By End-User, 2018-2030

10.3. Germany

10.3.1. Germany Point of Care Testing Revenue (USD Billion) and Forecast By Product, 2018-2030

10.3.2. Germany Point of Care Testing Revenue (USD Billion) and Forecast By Technology, 2018-2030

10.3.3. Germany Point of Care Testing Revenue (USD Billion) and Forecast By Prescription, 2018-2030

10.3.4. Germany Point of Care Testing Revenue (USD Billion) and Forecast By Application, 2018-2030

10.3.5. Germany Point of Care Testing Revenue (USD Billion) and Forecast By End-User, 2018-2030

10.4. France

10.4.1. France Point of Care Testing Revenue (USD Billion) and Forecast By Product, 2018-2030

10.4.2. France Point of Care Testing Revenue (USD Billion) and Forecast By Technology, 2018-2030

10.4.3. France Point of Care Testing Revenue (USD Billion) and Forecast By Prescription, 2018-2030

10.4.4. France Point of Care Testing Revenue (USD Billion) and Forecast By Application, 2018-2030

10.4.5. France Point of Care Testing Revenue (USD Billion) and Forecast By End-User, 2018-2030

10.5. Spain

10.5.1. Spain Point of Care Testing Revenue (USD Billion) and Forecast By Product, 2018-2030

10.5.2. Spain Point of Care Testing Revenue (USD Billion) and Forecast By Technology, 2018-2030

10.5.3. Spain Point of Care Testing Revenue (USD Billion) and Forecast By Prescription, 2018-2030

10.5.4. Spain Point of Care Testing Revenue (USD Billion) and Forecast By Application, 2018-2030

10.5.5. Spain Point of Care Testing Revenue (USD Billion) and Forecast By End-User, 2018-2030

10.6. Rest of Europe

10.6.1. Rest of Europe Point of Care Testing Revenue (USD Billion) and Forecast By Product, 2018-2030

10.6.2. Rest of Europe Point of Care Testing Revenue (USD Billion) and Forecast By Technology, 2018-2030

10.6.3. Rest of Europe Point of Care Testing Revenue (USD Billion) and Forecast By Prescription, 2018-2030

10.6.4. Rest of Europe Point of Care Testing Revenue (USD Billion) and Forecast By Application, 2018-2030

10.6.5. Rest of Europe Point of Care Testing Revenue (USD Billion) and Forecast By End-User, 2018-2030

10.7. Europe PEST Analysis

CHAPTER 11. Asia Pacific Point of Care Testing Market By Country

11.1. Asia Pacific Point of Care Testing Market Overview

11.2. China

11.2.1. China Point of Care Testing Revenue (USD Billion) and Forecast By Product, 2018-2030

11.2.2. China Point of Care Testing Revenue (USD Billion) and Forecast By Technology, 2018-2030

11.2.3. China Point of Care Testing Revenue (USD Billion) and Forecast By Prescription, 2018-2030

11.2.4. China Point of Care Testing Revenue (USD Billion) and Forecast By Application, 2018-2030

11.2.5. China Point of Care Testing Revenue (USD Billion) and Forecast By End-User, 2018-2030

11.3. Japan

11.3.1. Japan Point of Care Testing Revenue (USD Billion) and Forecast By Product, 2018-2030

11.3.2. Japan Point of Care Testing Revenue (USD Billion) and Forecast By Technology, 2018-2030

11.3.3. Japan Point of Care Testing Revenue (USD Billion) and Forecast By Prescription, 2018-2030

11.3.4. Japan Point of Care Testing Revenue (USD Billion) and Forecast By Application, 2018-2030

11.3.5. Japan Point of Care Testing Revenue (USD Billion) and Forecast By End-User, 2018-2030

11.4. India

11.4.1. India Point of Care Testing Revenue (USD Billion) and Forecast By Product, 2018-2030

11.4.2. India Point of Care Testing Revenue (USD Billion) and Forecast By Technology, 2018-2030

11.4.3. India Point of Care Testing Revenue (USD Billion) and Forecast By Prescription, 2018-2030

11.4.4. India Point of Care Testing Revenue (USD Billion) and Forecast By Application, 2018-2030

11.4.5. India Point of Care Testing Revenue (USD Billion) and Forecast By End-User, 2018-2030

11.5. Australia

11.5.1. Australia Point of Care Testing Revenue (USD Billion) and Forecast By Product, 2018-2030

11.5.2. Australia Point of Care Testing Revenue (USD Billion) and Forecast By Technology, 2018-2030

11.5.3. Australia Point of Care Testing Revenue (USD Billion) and Forecast By Prescription, 2018-2030

11.5.4. Australia Point of Care Testing Revenue (USD Billion) and Forecast By Application, 2018-2030

11.5.5. Australia Point of Care Testing Revenue (USD Billion) and Forecast By End-User, 2018-2030

11.6. South Korea

11.6.1. South Korea Point of Care Testing Revenue (USD Billion) and Forecast By Product, 2018-2030

11.6.2. South Korea Point of Care Testing Revenue (USD Billion) and Forecast By Technology, 2018-2030

11.6.3. South Korea Point of Care Testing Revenue (USD Billion) and Forecast By Prescription, 2018-2030

11.6.4. South Korea Point of Care Testing Revenue (USD Billion) and Forecast By Application, 2018-2030

11.6.5. South Korea Point of Care Testing Revenue (USD Billion) and Forecast By End-User, 2018-2030

11.7. Rest of Asia-Pacific

11.7.1. Rest of Asia-Pacific Point of Care Testing Revenue (USD Billion) and Forecast By Product, 2018-2030

11.7.2. Rest of Asia-Pacific Point of Care Testing Revenue (USD Billion) and Forecast By Technology, 2018-2030

11.7.3. Rest of Asia-Pacific Point of Care Testing Revenue (USD Billion) and Forecast By Prescription, 2018-2030

11.7.4. Rest of Asia-Pacific Point of Care Testing Revenue (USD Billion) and Forecast By Application, 2018-2030

11.7.5. Rest of Asia-Pacific Point of Care Testing Revenue (USD Billion) and Forecast By End-User, 2018-2030

11.8. Asia Pacific PEST Analysis

CHAPTER 12. Latin America Point of Care Testing Market By Country

12.1. Latin America Point of Care Testing Market Overview

12.2. Brazil

12.2.1. Brazil Point of Care Testing Revenue (USD Billion) and Forecast By Product, 2018-2030

12.2.2. Brazil Point of Care Testing Revenue (USD Billion) and Forecast By Technology, 2018-2030

12.2.3. Brazil Point of Care Testing Revenue (USD Billion) and Forecast By Prescription, 2018-2030

12.2.4. Brazil Point of Care Testing Revenue (USD Billion) and Forecast By Application, 2018-2030

12.2.5. Brazil Point of Care Testing Revenue (USD Billion) and Forecast By End-User, 2018-2030

12.3. Mexico

12.3.1. Mexico Point of Care Testing Revenue (USD Billion) and Forecast By Product, 2018-2030

12.3.2. Mexico Point of Care Testing Revenue (USD Billion) and Forecast By Technology, 2018-2030

12.3.3. Mexico Point of Care Testing Revenue (USD Billion) and Forecast By Prescription, 2018-2030

12.3.4. Mexico Point of Care Testing Revenue (USD Billion) and Forecast By Application, 2018-2030

12.3.5. Mexico Point of Care Testing Revenue (USD Billion) and Forecast By End-User, 2018-2030

12.4. Rest of Latin America

12.4.1. Rest of Latin America Point of Care Testing Revenue (USD Billion) and Forecast By Product, 2018-2030

12.4.2. Rest of Latin America Point of Care Testing Revenue (USD Billion) and Forecast By Technology, 2018-2030

12.4.3. Rest of Latin America Point of Care Testing Revenue (USD Billion) and Forecast By Prescription, 2018-2030

12.4.4. Rest of Latin America Point of Care Testing Revenue (USD Billion) and Forecast By Application, 2018-2030

12.4.5. Rest of Latin America Point of Care Testing Revenue (USD Billion) and Forecast By End-User, 2018-2030

12.5. Latin America PEST Analysis

CHAPTER 13. Middle East & Africa Point of Care Testing Market By Country 

13.1. Middle East & Africa Point of Care Testing Market Overview

13.2. GCC

13.2.1. GCC Point of Care Testing Revenue (USD Billion) and Forecast By Product, 2018-2030

13.2.2. GCC Point of Care Testing Revenue (USD Billion) and Forecast By Technology, 2018-2030

13.2.3. GCC Point of Care Testing Revenue (USD Billion) and Forecast By Prescription, 2018-2030

13.2.4. GCC Point of Care Testing Revenue (USD Billion) and Forecast By Application, 2018-2030

13.2.5. GCC Point of Care Testing Revenue (USD Billion) and Forecast By End-User, 2018-2030

13.3. South Africa

13.3.1. South Africa Point of Care Testing Revenue (USD Billion) and Forecast By Product, 2018-2030

13.3.2. South Africa Point of Care Testing Revenue (USD Billion) and Forecast By Technology, 2018-2030

13.3.3. South Africa Point of Care Testing Revenue (USD Billion) and Forecast By Prescription, 2018-2030

13.3.4. South Africa Point of Care Testing Revenue (USD Billion) and Forecast By Application, 2018-2030

13.3.5. South Africa Point of Care Testing Revenue (USD Billion) and Forecast By End-User, 2018-2030

13.4. Rest of Middle East & Africa

13.4.1. Rest of Middle East & Africa Point of Care Testing Revenue (USD Billion) and Forecast By Product, 2018-2030

13.4.2. Rest of Middle East & Africa Point of Care Testing Revenue (USD Billion) and Forecast By Technology, 2018-2030

13.4.3. Rest of Middle East & Africa Point of Care Testing Revenue (USD Billion) and Forecast By Prescription, 2018-2030

13.4.4. Rest of Middle East & Africa Point of Care Testing Revenue (USD Billion) and Forecast By Application, 2018-2030

13.4.5. Rest of Middle East & Africa Point of Care Testing Revenue (USD Billion) and Forecast By End-User, 2018-2030

13.5. Middle East & Africa PEST Analysis

CHAPTER 14. Player Analysis Of Point of Care Testing Market

14.1. Point of Care Testing Market Company Share Analysis

14.2. Competition Matrix

14.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment

14.2.2. New Product Launches and Product Enhancements

14.2.3. Mergers And Acquisition In Global Point of Care Testing Market

14.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements

CHAPTER 15. Company Profile

15.1. Abbott Laboratories

15.1.1. Company Snapshot

15.1.2. Business Overview

15.1.3. Financial Overview

15.1.3.1. Revenue (USD Billion), 2021

15.1.3.2. Abbott Laboratories 2021 Point of Care Testing Business Regional Distribution

15.1.4. Product /Service and Specification

15.1.5. Recent Developments & Business Strategy

15.2. Becton Dickinson (BD)

15.3. Biomerieux SA

15.4. Danaher Corp.

15.5. F. Hoffmann-La Roche Ltd.

15.6. Instrumentation Laboratory

15.7. Nova Biomedical

15.8. Qiagen

15.9. Siemens Healthcare AG

15.10. Trividia Health, Inc.

15.11. Zoetis, Inc.

Ask Query Here: sales@acumenresearchandconsulting.com

To Purchase this Premium Report@https://www.acumenresearchandconsulting.com/buy-now/0/1136 

About Us

Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets.

ARC helps investment communities, IT professionals, and business executives to make fact based decisions on technology purchases and develop firm growth strategies to sustain market competition.

With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.

Contact Us:

Mr. Frank Wilson
Acumen Research and Consulting
USA: + 13474743864
India: +918983225533
E-mail: sales@acumenresearchandconsulting.com

admin

Leave a Reply

Your email address will not be published. Required fields are marked *